The study revealed an independent association of high NLR ≥ 2.0 with shorter OS in general (p = 0.037), but also in distinct subgroups of patients such those with triple-negative BC (p = 0.029) or exhibiting HER2 overexpression (p = 0.019) [96]. The gene discussed is ERBB2; the disease is breast cancer.